Merck plans to manufacture COVID-19 antiviral drug in Canada

CBC News | Dec. 6, 2021, 6:39 a.m. | Original

Merck Canada announced Monday it plans to manufacture its oral antiviral COVID-19 drug in Canada, making the country a global hub for the production of the potentially game-changing treatment.

Surgeon handed 4-month suspension for noose incident at Alberta hospital Ransomware attacks in Canada are brazen, sophisticated and very profitable for criminals: cyber spy agency